Manhattan Scientifics, Inc. (MHTX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Common stock issued for services
Stock based compensation related to vesting of stock warrants	240K
Depreciation and amortization
Prepaid expenses and other assets	0
Unbilled revenue
Accounts payable and accrued expenses	730K
Accrued interest and expenses-related parties
Deferred revenue	27K
Net cash used in operating activities;
Net cash provided by investing activities
Proceeds from issuance of common stock, net of offering costs
Net cash provided by financing activities
NET DECREASE IN CASH AND CASH EQUIVALENTS	-3.64M
Cash and cash equivalents, beginning of period	5.36M
CASH AND CASH EQUIVALENTS, END OF PERIOD	1.73M
Interest paid	100K
Income taxes paid	0
14,000,000 shares of common stock issued for acquisition of Scientific Nanomedicine, Inc.
1,000 shares of common stock issued for the acquisition of Senior Scientific, LLC

Entities mentioned with MHTX

View All Entities